Cerus adds board member
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback
Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook
Cerus Corp. appointed Eric Bjerkholt as a director.
Bjerkholt is the CFO of Aimmune Therapeutics Inc., which develops treatments for people with food allergies. He is also a board member at Corium International Inc.
Concord, Calif.-based Cerus develops biomedical products, with a focus on blood transfusion safety.
